Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A responsiveness in CRPS-related fixed dystonia
NL-OMON34320Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in complex regional pain syndrome (CRPS) and dystonia (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Difference in EDB CMAP amplitude pre- and post-BoNT/A in affected CRPS limb versus controls, Difference in EDB CMAP amplitude pre- and post-BoNT/A in unaffected CRPS limb versus controls and 1 more. Started Nov 2010; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
complex regional pain syndrome (CRPS)dystonia
Beyond the preview
Go deeper on NL-OMON34320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34320.